Telomerase Detection in Body Fluids. Telomerase Detection in Body Fluids.

Telomerase Detection in Body Fluids‪.‬

Clinical Chemistry 2002, Jan, 48, 1

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

The ends of chromosomes are stabilized and protected from degradation by intercellular nucleases by specialized nucleoprotein structures, the telomeres. The DNA component of telomeres consists of many hundreds to thousands of simple repeat sequences. In mammals, this sequence is 5'-TTAGGG-3' (1-3). Because the DNA replication machinery cannot fully replicate the ends of linear DNA, telomeres progressively shorten with each round of cell replication (4). Eventually, a critically short telomere length is reached, and the cell stops dividing and senesces (5-7). This phenomenon is thought to function as a type of "molecular clock", limiting the lifespan of individual cells. However, cell types that, as part of their normal biology, must replicate for many rounds of cell division, e.g., germ cells, embryonic cells, and stem cells, must posses a mechanism to "reset the clock" (8, 9). This mechanism is provided by the enzyme telomerase, a ribonucleoprotein that recognizes the ends of telomeres and adds additional repeats (1-3). In most postembryonic cell types, telomerase activity is down-regulated; in cancer cells, however, telomerase expression is activated (8-11). Therefore, telomerase has been the focus of much research over the past several years, with increasing interest in the role of this enzyme in carcinogenesis, as a target for anticancer chemotherapy, and as a biomarker for the detection of cancer. Telomerase is a ribonucleoprotein consisting of three components: two protein subunits and an RNA subunit. The catalytic core consists of hTERT, the catalytic subunit that possesses reverse transcriptase activity, and hTR, the coding RNA component (12-14). The second telomerase protein, hTP, may play a structural role. hTR and hTP are expressed ubiquitously, with hTERT expression being the rate-limiting step for telomerase activity (15).

GENRE
Wissenschaft und Natur
ERSCHIENEN
2002
1. Januar
SPRACHE
EN
Englisch
UMFANG
19
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
GRÖSSE
174,1
 kB

Mehr ähnliche Bücher

Liquid Biopsy in Urogenital Cancers and its Clinical Utility (Enhanced Edition) Liquid Biopsy in Urogenital Cancers and its Clinical Utility (Enhanced Edition)
2022
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1 Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 1
2014
The Sporadic Nature of Shedding Cells in Blood: Multiple RNA Diagnostic Testing and Prognostication of Cancer Progression (Editorial) The Sporadic Nature of Shedding Cells in Blood: Multiple RNA Diagnostic Testing and Prognostication of Cancer Progression (Editorial)
2003
Anticancer Therapeutics Anticancer Therapeutics
2017
Principles and Applications of Molecular Diagnostics Principles and Applications of Molecular Diagnostics
2018
Systems Biology of Cancer Systems Biology of Cancer
2015

Mehr Bücher von Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998